‘We would not want the pharmacy profession being set up to fail.’

Stakeholders have welcomed an interim TGA decision to downschedule low-dose cannabidiol to S3 – but the peak pharmacist body warns that evidence and therapeutic purpose are key The TGA has released a notice of an interim decision to amend the Poisons Standard for CBD, proposing to downschedule certain products from S4 to S3 (Pharmacist Only